Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma

Author:

Daling Janet R.,Malone Kathleen E.,Doody David R.,Voigt Lynda F.,Bernstein Leslie,Coates Ralph J.,Marchbanks Polly A.,Norman Sandra A.,Weiss Linda K.,Ursin Giske,Berlin Jesse A.,Burkman Ronald T.,Deapen Dennis,Folger Suzanne G.,McDonald Jill A.,Simon Michael S.,Strom Brian L.,Wingo Phyllis A.,Spirtas Robert

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference28 articles.

1. Changing incidence rate of invasive lobular breast carcinoma among older women

2. Surveillance, Epidemiology, and End Results (SEER) Program. Public-use data (1973-1998) released April 2001 [based on the August 2000 submission]. Bethesda: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, 2001.

3. Post-menopausal hormone use and risk of breast cancer by histologic type. Presented at the Society of Epidemiologic Research 1999 SER Meeting, Baltimore, MD June 10-12, 1999.

4. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

5. Hormone Replacement Therapy in Relation to Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3